peoplePerson
Hatem Soliman
Hatem Soliman is a breast oncologist leading immunotherapy and genomic-assay trials, including in triple-negative disease.
Medical director of Moffitt's clinical trials office; investigator in TNBC immunotherapy studies and validation of breast genomic classifiers.
Role
Medical Director, Clinical Trials Office; Breast Oncology
Institution
Specialisms
Breast cancerImmunotherapyGenomic assays
Profiles
| Title | Journal | Year |
|---|---|---|
| A phase 2 study of the IDO inhibitor indoximod with chemotherapy in metastatic breast cancer | Cancer Immunology Research | 2018 |